Mri Prospective Survey On Cardiac And Hepatic Iron In Thalassemia Intermedia Patients Treated With Desferrioxamine, Deferiprone And Deferasirox

Background. Few studies have evaluated the efficacy of iron chelation therapy in thalassemia intermedia (TI) patients. Our study aimed to prospectively assess by quantitative Magnetic Resonance imaging (MRI) the efficacy of the three available chelators in monotherapy in transfusion dependent (TD) TI patients.